Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Inspire Veterinary Partners (IVPR) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for Inspire Veterinary Partners (IVPR) over the last 4 years, with Q3 2025 value amounting to $969940.0.

  • Inspire Veterinary Partners' Accumulated Expenses rose 21789.01% to $969940.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $969940.0, marking a year-over-year increase of 21789.01%. This contributed to the annual value of $285770.0 for FY2024, which is 6670.64% down from last year.
  • As of Q3 2025, Inspire Veterinary Partners' Accumulated Expenses stood at $969940.0, which was up 21789.01% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Inspire Veterinary Partners' Accumulated Expenses registered a high of $1.0 million during Q2 2025, and its lowest value of $285770.0 during Q4 2024.
  • In the last 4 years, Inspire Veterinary Partners' Accumulated Expenses had a median value of $667025.5 in 2022 and averaged $671046.8.
  • As far as peak fluctuations go, Inspire Veterinary Partners' Accumulated Expenses tumbled by 6670.64% in 2024, and later soared by 21789.01% in 2025.
  • Inspire Veterinary Partners' Accumulated Expenses (Quarter) stood at $690740.0 in 2022, then rose by 24.26% to $858334.0 in 2023, then tumbled by 66.71% to $285770.0 in 2024, then skyrocketed by 239.41% to $969940.0 in 2025.
  • Its Accumulated Expenses stands at $969940.0 for Q3 2025, versus $1.0 million for Q2 2025 and $643311.0 for Q1 2025.